Clover Health Investments (CLOV) Q1 Revenue Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Clover Health Reports First Quarter 2022 Financial Results
May 9, 2022 4:05 PM EDTFirst quarter total revenue was $874.4 million, compared to $200.3 million in first quarter 2021
Lives under Clover Management grew to ~257,000 from ~66,000 year-over-year
First quarter Insurance (Medicare Advantage) Medical Care Ratio (MCR) of 96.4% and Non-Insurance (Direct Contracting) MCR of 99.8% show significant improvement quarter-over-quarter
Full-year 2022 revenue expected to be $3.0 billion to $3.4 billion
Clover continues to expect 2022 Insurance MCR of 95% to 99% and a further step-wise improvement beyond
FRANKLIN, Tenn., May 09, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq:... More
